TJTomasz Jargiełło

Tomasz Jargiełło

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tomasz Jargiełło has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Recurrent haemoptysis due to pulmonary aspergillosis treated with endovascular embolization – case report

    by Grzegorz Jama, Maciej Szmygin, Katarzyna Szmygin-Milanowska, Michał Sojka, Tomasz Jargiełło

    Aspergilloma is a disease characterized by the formation of saprophytic fungal colonies in pulmonary cavities. Haemoptysis is the most common clinical presentation which may range from mild to life-threatening. Treatment options include conservative management, surgical resection and bronchial...

  • Diagnostic accuracy of microvascular flow imaging ultrasound for endoleak detection after endovascular aortic aneurysm repair: a systematic review and meta-analysis

    by Marcin Czeczelewski, Ewa Kopyto, Maryla Kuczyńska, Anna Drelich-Zbroja, Tomasz Jargiełło

    The objective was to assess the diagnostic accuracy of microvascular flow imaging ultrasound (MVUS) for the detection of endoleak after endovascular aortic aneurysm repair. A systematic search of the literature published until January 2024 was performed according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses of Diagnostic Test Accuracy (PRISMA-DTA) guidelines. The pooled rates of sensitivity, specificity, and diagnostic odds ratio of MVUS in endoleak detection with computed tomography angiography as the reference standard were estimated using univariate random-effect analysis with 95% confidence intervals. Three studies were considered eligible for inclusion. Superb micro vascular imaging (SMI) was used as an MVUS technique in all cases. The total number of paired scans was 209. Sensitivity and specificity of the individual studies ranged 0.75-1.00 and 0.93-1.00, respectively. Pooled sensitivity and specificity of the SMI method was 0.91 (CI: 0.82-0.96) and 0.98 (CI: 0.94-1.00), respectively. The pooled diagnostic odds ratio was 635 (95% CI: 128-3140). The findings of the present study support the use of the MVUS for endoleak detection. However, further research is warranted to explore the broader application of MVUS, providing a more comprehensive understanding and establishing robust criteria for its role in clinical practice.


  • Open Access

    Contrast-Enhanced Ultrasound Feasibility in Assessing Carotid Plaque Vulnerability—Narrative Review

    by Ewa Kopyto, Marcin Czeczelewski, Eryk Mikos, Karol Stępniak, Maja Kopyto, Małgorzata Matuszek, Karolina Nieoczym, Adam Czarnecki, Maryla Kuczyńska, Mateusz Cheda, et al.

    The risk assessment for carotid atherosclerotic lesions involves not only determining the degree of stenosis but also plaque morphology and its composition. Recently, carotid contrast-enhanced ultrasound (CEUS) has gained importance for evaluating vulnerable plaques. This review explores CEUS’s utility in detecting carotid plaque surface irregularities and ulcerations as well as intraplaque neovascularization and its alignment with histology. Initial indications suggest that CEUS might have the potential to anticipate cerebrovascular incidents. Nevertheless, there is a need for extensive, multicenter prospective studies that explore the relationships between CEUS observations and patient clinical outcomes in cases of carotid atherosclerotic disease.


  • Open Access

    Uncommon complication of a common procedure

    by Krzysztof Pyra, Maciej Szmygin, Eryk Mikos, Marcin Czeczelewski, Sara Moqbil, Rafał Celiński, Tomasz Jargiełło

    W w w. j o u r n a l s. v i a m e d i c a. p l / k a r d i o l o g i a _ p o l s k a 412

  • Open Access

    Byrd sheaths for complex inferior vena cava filter retrieval: Results of a preliminary study

    by Maciej Szmygin, Wanesa Góralczyk, Damian Wach, Tomasz Jargiełło, Krzysztof Pyra

  • Open Access

    Unilateral Uterine Artery Embolization as a Treatment for Patients with Symptomatic Fibroids—Experience in a Case Series

    by Krzysztof Pyra, Maciej Szmygin, Hanna Szmygin, Sławomir Woźniak, Tomasz Jargiełło

    Background and Objectives: Uterine artery embolization (UAE) has become an accepted and widely performed therapy for patients with symptomatic (reporting at least two of the following symptoms: severe or prolonged menstrual bleeding, abdominal pain, tension in abdomen, problems with urination, constipation or anemia) uterine fibroids. Although in the majority of cases, bilateral occlusion is required to obtain a successful clinical outcome, there are patients in whom treatment of only one uterine artery could be attempted. There are several reasons for unilateral UAE: hemodynamic conditions, technical difficulties, anatomical variants and unilateral dominancy of blood supply to the fibroid. Our aim is to present our 10-year experience with unilateral UAE and evaluate the radiological and clinical outcomes. Materials and Methods: Records of 369 patients with fibroids who underwent UAE from 2010 to 2021 were analyzed. We identified 26 patients treated with unilateral uterine artery embolization and analyzed the data of these patients. All patients attended medical consultation, were assessed using a five-grade symptom scale and underwent MRI examination. Clinical response was evaluated at least 6 months after the procedure and was categorized to one of the following groups: complete improvement, partial improvement, no change and a worsening in symptoms. Results: Twenty-two patients (85%) reported at least partial improvement 6 months following the procedure. One patient required secondary embolization due to recanalization. The secondary procedure was successful, and complete improvement was achieved. One patient did not observe any clinical improvement, and in two cases, symptom recurrence was observed. All three patients were referred for surgical treatment. No major complications were noted. Overall, the success rate was 88%. Conclusions: The results of our study support the statement that elective unilateral embolization is an appropriate treatment in patients with a dominant uterine artery.


  • Open Access

    Chemoembolization as a minimally invasive treatment of primary malignant liver cancer

    by Katarzyna Szklener, Weronika Kuryło, Anna Rodzajewska, Łukasz Światłowski, Tomasz Jargiełło, Sławomir Mańdziuk

    Background: Hepatocellular carcinoma (HCC) is the most common type of liver cancer and one of the most malignant neoplasms with high incidence and mortality in humans worldwide. The complex nature of the disease and its high resistance to systemic therapies result in poor prognosis for patients with advanced HCC. Case Report: In March 2017, the patient was admitted to the Department of Oncological Surgery, where a non-anatomical tumor resection was performed. Three years later, the patient developed a single change in segment 8 of the liver that was a relapse of the neoplastic process. Based on the Bracelon Criteria, the patient was qualified for the 1st stage of chemoembolization using the Seldinger method. In the presented patient as a result of the applied treatment, the neoplastic process was stabilized. Conclusion: The chemoembolization treatment that was applied to the presented patient turned out to be the correct treatment option. After only the first stage of chemoembolization, the patient regressed the neoplastic lesion.

  • SELECTING PATIENTS FOR EMBOLIZATION OF VARICOCELES BASED ON ULTRASONOGRAPHY

    by Izabela Dąbrowska, Łukasz Światłowski, Krzysztof Pyra, Tomasz Jargiełło, Agata Zarajczyk, i Maria Materek

  • Open Access

    Endovascular Treatment of Acute Ischemic Stroke With the Penumbra System in Routine Practice: COMPLETE Registry Results

    by Osama O. Zaidat, Johanna T. Fifi, Ashish Nanda, Benjamin Atchie, Keith Woodward, Arnd Doerfler, Alejandro Tomasello, Wondwossen Tekle, Inder Paul Singh, Charles Matouk, et al.

    Background and Purpose: The purpose of the COMPLETE (International Acute Ischemic Stroke Registry With the Penumbra System Aspiration Including the 3D Revascularization Device) registry was to evaluate the generalizability of the safety and efficacy of the Penumbra System (Penumbra, Inc, Alameda) in a real-world setting. Methods: COMPLETE was a global, prospective, postmarket, multicenter registry. Patients with large vessel occlusion–acute ischemic stroke who underwent mechanical thrombectomy using the Penumbra System with or without the 3D Revascularization Device as frontline approach were enrolled at 42 centers (29 United States, 13 Europe) from July 2018 to October 2019. Primary efficacy end points were successful postprocedure angiographic revascularization (modified Thrombolysis in Cerebral Infarction ≥2b) and 90-day functional outcome (modified Rankin Scale score 0–2). The primary safety end point was 90-day all-cause mortality. An imaging core lab determined modified Thrombolysis in Cerebral Infarction scores, Alberta Stroke Program Early CT Scores, clot location, and occurrence of intracranial hemorrhage at 24 hours. Independent medical reviewers adjudicated safety end points. Results: Six hundred fifty patients were enrolled (median age 70 years, 54.0% female, 49.2% given intravenous recombinant tissue-type plasminogen activator before thrombectomy). Rate of modified Thrombolysis in Cerebral Infarction 2b to 3 postprocedure was 87.8% (95% CI, 85.3%–90.4%). First pass and postprocedure rates of modified Thrombolysis in Cerebral Infarction 2c to 3 were 41.5% and 66.2%, respectively. At 90 days, 55.8% (95% CI, 51.9%–59.7%) had modified Rankin Scale score 0 to 2, and all-cause mortality was 15.5% (95% CI, 12.8%–18.3%). Conclusions: Using Penumbra System for frontline mechanical thrombectomy treatment of patients with large vessel occlusion–acute ischemic stroke in a real-world setting was associated with angiographic, clinical, and safety outcomes that were comparable to prior randomized clinical trials with stringent site and operator selection criteria. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03464565.


  • Open Access

    Endovascular treatment of vertebrobasilar system aneurysms — long term results

    by Paweł Szmygin, Maciej Szmygin, Tomasz Roman, Tomasz Jargiełło

    Introduction: Microsurgical treatment of VBSA is complex and challenging due to the deep location of the vessels and the proximity of important structures. Therefore, minimally invasive endovascular techniques have been introduced to the treatment of VBSA. The aim of this study was to present long-term results and technical aspects of VBSA embolisation. In this manuscript, we describe our experience in the treatment of VBSA with long-term results. Furthermore, we discuss the advantages and disadvantages of this treatment modality, paying special attention to the technical aspects. We believe that this is an important contribution to this topic because the number of previous reports is limited. It adds to a population that can be compared to patients treated using different methods. Materials and methods: We analysed the medical records of patients with aneurysms of vertebral and basilar arteries referred for endovascular treatment between 2015 and 2020. Results: A total of 44 patients were selected for the study. From this group, 10 patients (22.7%) were admitted with SAH caused by ruptured VBSA. The median age of the patients was 58 years (31-80), with 27 (61.4%) females and 17 (38.6%) males. The majority of the VBSAs (35, 79.5%) were located on the basilar artery. Complete occlusion was achieved in 39 patients (88.6%). Procedural complications occurred in three cases (6.8%). In long-term follow-up, complete embolisation was achieved in 81.8% (36 of 44 patients). In 18.2% (eight patients), recurrence of VBSA was observed. Two patients were qualified for recoiling. Clinical follow-up was uneventful in 37 (84%) patients. Four patients (9%) reported mild headaches. Three (7%) patients required assistance for daily living. Conclusions: Endovascular embolisation of VBSA is feasible and provides an excellent rate of complete occlusion and a high rate of favourable long-term outcomes, which support using this technique as a first-line treatment. A relatively high rate of recurrence remains the major drawback, especially in cases of wide-neck VBSA. Introduction: Microsurgical treatment of VBSA is complex and challenging due to the deep location of the vessels and the proximity of important structures. Therefore, minimally invasive endovascular techniques have been introduced to the treatment of VBSA. The aim of this study was to present long-term results and technical aspects of VBSA embolisation. In this manuscript, we describe our experience in the treatment of VBSA with long-term results. Furthermore, we discuss the advantages and disadvantages of this treatment modality, paying special attention to the technical aspects. We believe that this is an important contribution to this topic because the number of previous reports is limited. It adds to a population that can be compared to patients treated using different methods. Materials and methods: We analysed the medical records of patients with aneurysms of vertebral and basilar arteries referred for endovascular treatment between 2015 and 2020. Results: A total of 44 patients were selected for the study. From this group, 10 patients (22.7%) were admitted with SAH caused by ruptured VBSA. The median age of the patients was 58 years (31-80), with 27 (61.4%) females and 17 (38.6%) males. The majority of the VBSAs (35, 79.5%) were located on the basilar artery. Complete occlusion was achieved in 39 patients (88.6%). Procedural complications occurred in three cases (6.8%). In long-term follow-up, complete embolisation was achieved in 81.8% (36 of 44 patients). In 18.2% (eight patients), recurrence of VBSA was observed. Two patients were qualified for recoiling. Clinical follow-up was uneventful in 37 (84%) patients. Four patients (9%) reported mild headaches. Three (7%) patients required assistance for daily living. Conclusions: Endovascular embolisation of VBSA is feasible and provides an excellent rate of complete occlusion and a high rate of favourable long-term outcomes, which support using this technique as a first-line treatment. A relatively high rate of recurrence remains the major drawback, especially in cases of wide-neck VBSA.